417 related articles for article (PubMed ID: 24189070)
1. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
[TBL] [Abstract][Full Text] [Related]
2. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
[TBL] [Abstract][Full Text] [Related]
4. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
[TBL] [Abstract][Full Text] [Related]
5. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L
J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660
[TBL] [Abstract][Full Text] [Related]
7. Absence of kynurenine 3-monooxygenase reduces mortality of acute viral myocarditis in mice.
Kubo H; Hoshi M; Mouri A; Tashita C; Yamamoto Y; Nabeshima T; Saito K
Immunol Lett; 2017 Jan; 181():94-100. PubMed ID: 27889626
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of kynurenine 3-monooxygenase exacerbates impairment of prepulse inhibition induced by phencyclidine.
Kubota H; Kunisawa K; Niijima M; Hirakawa M; Mori Y; Hasegawa M; Fujigaki S; Fujigaki H; Yamamoto Y; Saito K; Nabeshima T; Mouri A
Biochem Biophys Res Commun; 2022 Nov; 629():142-151. PubMed ID: 36116377
[TBL] [Abstract][Full Text] [Related]
9. On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo.
Amori L; Guidetti P; Pellicciari R; Kajii Y; Schwarcz R
J Neurochem; 2009 Apr; 109(2):316-25. PubMed ID: 19226371
[TBL] [Abstract][Full Text] [Related]
10. A novel causative role of imbalanced kynurenine pathway in ulcerative colitis: Upregulation of KMO and KYNU promotes intestinal inflammation.
Shi Y; Luo S; Zhai J; Chen Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166929. PubMed ID: 37918679
[TBL] [Abstract][Full Text] [Related]
11. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia.
Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G
Neuropharmacology; 2018 Aug; 138():130-139. PubMed ID: 29879409
[TBL] [Abstract][Full Text] [Related]
12. Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington's disease.
Bondulich MK; Fan Y; Song Y; Giorgini F; Bates GP
Sci Rep; 2021 Mar; 11(1):5484. PubMed ID: 33750843
[TBL] [Abstract][Full Text] [Related]
13. Kynurenine 3-monooxygenase is a critical regulator of renal ischemia-reperfusion injury.
Zheng X; Zhang A; Binnie M; McGuire K; Webster SP; Hughes J; Howie SEM; Mole DJ
Exp Mol Med; 2019 Feb; 51(2):1-14. PubMed ID: 30760699
[TBL] [Abstract][Full Text] [Related]
14. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
[TBL] [Abstract][Full Text] [Related]
15. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics.
Maddison DC; Alfonso-Núñez M; Swaih AM; Breda C; Campesan S; Allcock N; Straatman-Iwanowska A; Kyriacou CP; Giorgini F
PLoS Genet; 2020 Nov; 16(11):e1009129. PubMed ID: 33170836
[TBL] [Abstract][Full Text] [Related]
16. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
[TBL] [Abstract][Full Text] [Related]
17. Drosophila eye color mutants as therapeutic tools for Huntington disease.
Green EW; Campesan S; Breda C; Sathyasaikumar KV; Muchowski PJ; Schwarcz R; Kyriacou CP; Giorgini F
Fly (Austin); 2012; 6(2):117-20. PubMed ID: 22634544
[TBL] [Abstract][Full Text] [Related]
18. The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors.
Hughes TD; Güner OF; Iradukunda EC; Phillips RS; Bowen JP
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011505
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
20. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
Song P; Ramprasath T; Wang H; Zou MH
Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
